Henlix, Inc   Report issue

For profit Phase 1 Phase 2
Founded: Taipei Taiwan (2010)

Organization Overview

First Clinical Trial
2016
NCT02648490
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Henlix, Inc